添加微信 添加微信
添加微信
首页: 全球医药政策

奥地利-Evercyte

时间:2021-10-19 15:16:23 来源:康安医药咨询 作者:康安医药咨询

We apply two main technologies for generation of human cell lines that maintain their primary like functionality. The first technology for generation of human cell lines is by immortalization using the catalytic subunit of human telomerase (hTERT). Using ectopic overexpression of hTERT, cells can be immortalized without losing key cell type specific functionalities. For this, we have licenced in hTERT based patents from Geron Corp. The second technology is based on reprogramming human urine derived cells. This technology has been developed in cooperation with Guangzhou Institute of Biomedicine and health (GIBH), Chinese Academy of Sciences, China and is refined using integration free repromming based on mRNA transfections, licenced in from Fraunhofer Gesellschaft.

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:康安医药咨询

当前栏目

频道栏目

最新文章

热门文章